Insmed CEO Lewis William Balances Big Sell‑Offs with Strategic Buying in Latest 10‑b‑5‑1 Trades【Financial News Flash】
Insmed insider trading shows CEO Lewis William balancing large sales near $170 with strategic purchases at $30‑$17, signaling risk‑managed confidence amid biotech growth and volatility.
3 minutes to read